Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Among urothelial cancer patients treated with atezolizumab, those who used PPIs had a 68 percent greater risk of death.
Use of medications like Prilosec and Nexium were associated with a higher liver cancer rate in a recent large study.
Use of drugs like Nexium or Prilosec is tied to progression to cirrhosis, decompensated cirrhosis and liver cancer in this population.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.